ISSN Print 2713-2757    ISSN Online 2713-2765
Extreme Medicine
SCIENTIFIC AND PRACTICAL REVIEWED JOURNAL OF FMBA OF RUSSIA

Rudolf  VALENTA

Professor for Allergology,
Medical University of Vienna (Vienna, Austria)

Head of the Laboratory of Molecular Allergology,
Institute of Immunology of FMBA Russia (Moscow, Russia)

PhD, professor

Areas of expertise:

molecular, cellular and clinical allergology, immunology, development of diagnostic tests and vaccines for viral infections.

Special awards and honors:

2020 - Erich Fuchs Award of the German Society for Allergy and Clinical Immunology.

2020 - Guest Professor at Karl Landsteiner University of Health Sciences, Krems (Austria).

2018 - Global Allergology and Immunology Award of the Center for Pathophysiology, Infectiology and Immunology of the Medical University of Vienna (Austria).

2017 - Director of the new WAO Center of Excellence at MedUni Vienna, which comprises the SFB F46 allergy research program, the international MCCA PhD program and coordinates the international post-graduate teaching network INUNIMAI.

2016 - International Distinguished Fellow (IDF) Award of the American College of Allergy, Asthma & Immunology (ACAAI).

2016 - Foreign Adjunct Professor, Department of Medicine Solna, Karolinska   Institutet (Sweden).

2014 - Selected among best five scientists of the Medical University of Vienna (Austria).

2013 - Shortlisted for Else Kröner Fresenius Award.

2013 - “Würdigungspreis Wissenschaft 2013 des Landes Niederösterreich“.

2012 - “Inventor of the year 2012” of the Medical University of Vienna (Austria).

2011 - Forschungspreis ”Atopische Dermatitis” der Stiftung Pro Derma, Hamburg (Germany).

2009 - Paul Ehrlich Award for Experimental Research of the European Academy of Allergy and Clinical Immunology (EAACI).

2008 - President of the Austrian Society for Allergology and Immunology.

2006 - Corresponding member of the Austrian Academy of Sciences.

2001 - Alois Sonnleitner Award for Immunology of the Austrian Academy of Sciences.

2000 - 6th Sarstedt Award for the genetic analysis of allergy-eliciting substances and their recombinant production (after: J. Klose and P. H. O’Farrell 1986 Two-dimensional electrophoresis, H. Towbin, T. Staehelin and J. Gordon, Western blot 1988, M. Wilchek and E. A. Bayer Biotin-Avidin system 1990, F. S. Collins, J. R. Riordan, L.-C. Tsui Cystic fibrosis gene 1993, B. Vogelstein and D. Sidransky Molecular biology of malignant tumors 1997).

1998 - START Award of the Austrian Science Fund (FWF).

1996 - International Award of the Pharmacia Allergy Research Foundation.

1992 - Theodor Billroth Preis Vienna Medical Society.

1992 - Karl Landsteiner Award of the Austrian Society for Allergology and Immunology.

1992 - Gold Medal of the Foundation of Allergy Research of Europe (F.A.R.E.).

1991 - Clemens von Pirquet Preis of the Austrian Society for Allergology and Immunology.

Significant publications in last 5 years

1. Niespodziana, K., K. Stenberg-Hammar, S. Megremis, C.R. Cabauatan, K. Napora-Wijata, P.C. Vacal, D. Gallerano, C. Lupinek, D. Ebner, T. Schlederer, C. Harwanegg, C. Söderhäll, M. van Hage, G. Hedlin, N.G. Papadopoulos, and R. Valenta. 2018. PreDicta chip-based high resolution diagnosis of rhinovirus-induced wheeze. Nat Commun. 18: 2382. Doi: 10.1038/s41467-018-04591-0.

2. Wickman, M., C. Lupinek, N. Andersson, D. Belgrave, A. Asarnoj, M. Benet, M. Pinart, S. Wieser, J. Garcia-Aymerich, A. Baar, G. Pershagen, A. Simpson, I. Kull, A. Bergström, E. Melén, C. Hamsten, J.M. Antó, J. Bousquet, A. Custovic, R. Valenta R, and van Hage M. 2017. Detection of IgE reactivity to a handful of allergen molecules in early childhood predicts respiratory allergy in adolescence. EBioMedicine 26: 91. Doi: 10.1016/j.ebiom.2017.11.009.

3. Niederberger, V., A. Neubauer, P. Gevaert, M. Zidarn, M. Worm, W. Aberer, H.J. Malling, O. Pfaar, L. Klimek, W. Pfützner, J. Ring, U. Darsow, N. Novak, R. Gerth van Wijk, J. Eckl-Dorna, M. Focke-Tejkl, M. Weber, H.H. Müller, J. Klinger, F. Stolz, N. Breit, R. Henning, and R. Valenta. 2018. Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32. J Allergy Clin Immunol. 142: 497. Doi: 10.1016/j.jaci.2017.09.052.

4. Cornelius, C., K. Schöneweis, F. Georgi, M. Weber, V. Niederberger, P. Zieglmayer, K. Niespodziana, M. Trauner, H. Hofer, S. Urban, and R. Valenta. 2016. Immunotherapy with the PreS-based grass pollen allergy vaccine BM32 induces antibody responses protecting against Hepatitis B infection. EBioMedicine 11: 58, Doi: 10.1016/j.ebiom.2016.07.023.